Pancreatic cancer

John Christopher McAuliffe; John D. Christein

doi:10.1007/978-1-4939-1565-1_36

Pancreatic cancer

John Christopher McAuliffe, John D. Christein

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality in the United States, and annually, up to 230,000 people worldwide will die of PC. Approximately 43,000 will be diagnosed with PC in the United States this year, making it second only to colorectal cancer in tumors of gastrointestinal origin. The estimated overall 1-year survival rate is only 22 % with less than 5 % survival at 5 years-figures that underscore PC’s aggressive nature and the need for early detection. Surgical resection is the only potentially curative modality; however, even with advances in cross-sectional imaging and endoscopic diagnostics, only 15-20 % of patients will have resectable disease at presentation.

Original language	English (US)
Title of host publication	Common Surgical Diseases
Subtitle of host publication	An Algorithmic Approach to Problem Solving, Third Edition
Publisher	Springer New York
Pages	147-149
Number of pages	3
ISBN (Electronic)	9781493915651
ISBN (Print)	9781493915644
DOIs	https://doi.org/10.1007/978-1-4939-1565-1_36
State	Published - Jan 1 2015
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4939-1565-1_36

Cite this

@inbook{f495bee6bc9744bbab49df2ae2c07390,

title = "Pancreatic cancer",

abstract = "Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality in the United States, and annually, up to 230,000 people worldwide will die of PC. Approximately 43,000 will be diagnosed with PC in the United States this year, making it second only to colorectal cancer in tumors of gastrointestinal origin. The estimated overall 1-year survival rate is only 22 % with less than 5 % survival at 5 years-figures that underscore PC{\textquoteright}s aggressive nature and the need for early detection. Surgical resection is the only potentially curative modality; however, even with advances in cross-sectional imaging and endoscopic diagnostics, only 15-20 % of patients will have resectable disease at presentation.",

author = "McAuliffe, {John Christopher} and Christein, {John D.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1565-1_36",

language = "English (US)",

isbn = "9781493915644",

pages = "147--149",

booktitle = "Common Surgical Diseases",

publisher = "Springer New York",

}

TY - CHAP

T1 - Pancreatic cancer

AU - McAuliffe, John Christopher

AU - Christein, John D.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality in the United States, and annually, up to 230,000 people worldwide will die of PC. Approximately 43,000 will be diagnosed with PC in the United States this year, making it second only to colorectal cancer in tumors of gastrointestinal origin. The estimated overall 1-year survival rate is only 22 % with less than 5 % survival at 5 years-figures that underscore PC’s aggressive nature and the need for early detection. Surgical resection is the only potentially curative modality; however, even with advances in cross-sectional imaging and endoscopic diagnostics, only 15-20 % of patients will have resectable disease at presentation.

AB - Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality in the United States, and annually, up to 230,000 people worldwide will die of PC. Approximately 43,000 will be diagnosed with PC in the United States this year, making it second only to colorectal cancer in tumors of gastrointestinal origin. The estimated overall 1-year survival rate is only 22 % with less than 5 % survival at 5 years-figures that underscore PC’s aggressive nature and the need for early detection. Surgical resection is the only potentially curative modality; however, even with advances in cross-sectional imaging and endoscopic diagnostics, only 15-20 % of patients will have resectable disease at presentation.

UR - http://www.scopus.com/inward/record.url?scp=84945423343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945423343&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1565-1_36

DO - 10.1007/978-1-4939-1565-1_36

M3 - Chapter

AN - SCOPUS:84945423343

SN - 9781493915644

SP - 147

EP - 149

BT - Common Surgical Diseases

PB - Springer New York

ER -

Pancreatic cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this